ROG.S - Roche Holding AG
JPMorganEstimate Decrease, Price Target Decrease
Roche Remaining 2026 readouts, seem unlikely to lead to significant upgrades, with risk remaining around fenebrutinib
公司
ROG.S
日期
2026-03-12
分析师
Mr. Richard B. Vosser
页数
16 页
需要登录
请登录后购买研报或生成音频内容。